Loading...
Aclarion, Inc.
ACONW•NASDAQ
HealthcareMedical - Healthcare Information Services
$0.04
$0.006(20.46%)
Aclarion, Inc. (ACONW) Stock Overview
Explore Aclarion, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ACONWStats details for ACONW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ACONWAnalyst Recommendations details for ACONW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
CEO
Mr. Brent Ness
Employees
5
Headquarters
951 Mariners Island Boulevard, Broomfield, CA
Founded
1970